| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 77.04B | 78.15B | 78.56B | 29.02B | 26.26B | 26.91B |
| Gross Profit | 34.47B | 32.48B | 28.28B | 29.64B | 25.95B | 26.91B |
| EBITDA | 14.20B | 12.39B | 11.18B | 7.71B | 19.09B | 11.44B |
| Net Income | 9.73B | 8.71B | 7.32B | 4.42B | 13.54B | 7.75B |
Balance Sheet | ||||||
| Total Assets | 1.50T | 1.48T | 1.41T | 1.29T | 1.14T | 988.17B |
| Cash, Cash Equivalents and Short-Term Investments | 63.82B | 104.16B | 113.53B | 114.31B | 118.21B | 121.97B |
| Total Debt | 132.21B | 415.19B | 262.44B | 248.74B | 222.64B | 189.81B |
| Total Liabilities | 1.41T | 1.39T | 1.33T | 1.22T | 1.07T | 930.65B |
| Stockholders Equity | 85.57B | 88.05B | 84.25B | 77.01B | 71.04B | 57.52B |
Cash Flow | ||||||
| Free Cash Flow | 39.30B | 8.51B | 27.47B | 19.59B | 3.51B | 43.07B |
| Operating Cash Flow | 41.06B | 10.24B | 29.03B | 21.27B | 4.96B | 44.05B |
| Investing Cash Flow | -38.62B | 605.00M | -24.53B | -21.16B | -29.47B | -299.00M |
| Financing Cash Flow | -2.93B | -8.67B | -17.41B | 268.00M | 15.98B | 47.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
| ― | $114.17B | 16.17 | 11.25% | 3.61% | -3.41% | 22.43% | |
72 Outperform | C$363.87B | 16.64 | 15.37% | 2.58% | 1.99% | 22.50% | |
71 Outperform | C$78.55B | 16.88 | 12.83% | 2.64% | 6.36% | 7.80% | |
70 Outperform | C$139.88B | 14.06 | 14.75% | 3.07% | -3.32% | 27.25% | |
68 Neutral | C$135.67B | 14.25 | 11.06% | 4.32% | -5.52% | 47.19% | |
65 Neutral | C$263.87B | 17.57 | 17.26% | 3.34% | -11.69% | -11.99% |